UniProt ID | NGAL_HUMAN | |
---|---|---|
UniProt AC | P80188 | |
Protein Name | Neutrophil gelatinase-associated lipocalin | |
Gene Name | LCN2 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 198 | |
Subcellular Localization | Secreted . Upon binding to the SLC22A17 (24p3R) receptor, it is internalized. | |
Protein Description | Iron-trafficking protein involved in multiple processes such as apoptosis, innate immunity and renal development. Binds iron through association with 2,5-dihydroxybenzoic acid (2,5-DHBA), a siderophore that shares structural similarities with bacterial enterobactin, and delivers or removes iron from the cell, depending on the context. Iron-bound form (holo-24p3) is internalized following binding to the SLC22A17 (24p3R) receptor, leading to release of iron and subsequent increase of intracellular iron concentration. In contrast, association of the iron-free form (apo-24p3) with the SLC22A17 (24p3R) receptor is followed by association with an intracellular siderophore, iron chelation and iron transfer to the extracellular medium, thereby reducing intracellular iron concentration. Involved in apoptosis due to interleukin-3 (IL3) deprivation: iron-loaded form increases intracellular iron concentration without promoting apoptosis, while iron-free form decreases intracellular iron levels, inducing expression of the proapoptotic protein BCL2L11/BIM, resulting in apoptosis. Involved in innate immunity, possibly by sequestrating iron, leading to limit bacterial growth.. | |
Protein Sequence | MPLGLLWLGLALLGALHAQAQDSTSDLIPAPPLSKVPLQQNFQDNQFQGKWYVVGLAGNAILREDKDPQKMYATIYELKEDKSYNVTSVLFRKKKCDYWIRTFVPGCQPGEFTLGNIKSYPGLTSYLVRVVSTNYNQHAMVFFKKVSQNREYFKITLYGRTKELTSELKENFIRFSKSLGLPENHIVFPVPIDQCIDG | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
21 | Pyrrolidone_carboxylic_acid | GALHAQAQDSTSDLI HHHHHHHCCCCCCCC | 32.86 | 7683678 | |
21 | Pyrrolidone_carboxylic_acid | GALHAQAQDSTSDLI HHHHHHHCCCCCCCC | 32.86 | - | |
21 | Pyrrolidone_carboxylic_acid | GALHAQAQDSTSDLI HHHHHHHCCCCCCCC | 32.86 | 7683678 | |
23 | Phosphorylation | LHAQAQDSTSDLIPA HHHHHCCCCCCCCCC | 20.10 | 24505115 | |
72 | Phosphorylation | DKDPQKMYATIYELK CCCHHHHEEEEEECC | 13.97 | - | |
76 | Phosphorylation | QKMYATIYELKEDKS HHHEEEEEECCCCCC | 15.74 | - | |
79 | 2-Hydroxyisobutyrylation | YATIYELKEDKSYNV EEEEEECCCCCCCCE | 52.51 | - | |
83 | Phosphorylation | YELKEDKSYNVTSVL EECCCCCCCCEEEEE | 33.97 | 23403867 | |
84 | Phosphorylation | ELKEDKSYNVTSVLF ECCCCCCCCEEEEEE | 21.28 | 23403867 | |
85 | N-linked_Glycosylation | LKEDKSYNVTSVLFR CCCCCCCCEEEEEEE | 37.37 | 15084671 | |
85 | N-linked_Glycosylation | LKEDKSYNVTSVLFR CCCCCCCCEEEEEEE | 37.37 | 15084671 | |
87 | Phosphorylation | EDKSYNVTSVLFRKK CCCCCCEEEEEEEEC | 14.96 | 23403867 | |
88 | Phosphorylation | DKSYNVTSVLFRKKK CCCCCEEEEEEEECC | 16.73 | 23403867 | |
126 | Phosphorylation | SYPGLTSYLVRVVST CCCCCEEEEEEEEEC | 12.18 | - | |
132 | Phosphorylation | SYLVRVVSTNYNQHA EEEEEEEECCCCCEE | 14.21 | 30631047 | |
133 | Phosphorylation | YLVRVVSTNYNQHAM EEEEEEECCCCCEEE | 30.07 | - | |
154 | Acetylation | SQNREYFKITLYGRT HHCCCEEEEEEECCH | 33.60 | 25038526 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of NGAL_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of NGAL_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of NGAL_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
NGAL_HUMAN | LCN2 | physical | 7683678 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
N-linked Glycosylation | |
Reference | PubMed |
"Glycoproteomics analysis of human liver tissue by combination ofmultiple enzyme digestion and hydrazide chemistry."; Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.; J. Proteome Res. 8:651-661(2009). Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-85, AND MASS SPECTROMETRY. | |
"Identification of N-linked glycoproteins in human saliva byglycoprotein capture and mass spectrometry."; Ramachandran P., Boontheung P., Xie Y., Sondej M., Wong D.T.,Loo J.A.; J. Proteome Res. 5:1493-1503(2006). Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-85, AND MASS SPECTROMETRY. | |
"Human plasma N-glycoproteome analysis by immunoaffinity subtraction,hydrazide chemistry, and mass spectrometry."; Liu T., Qian W.-J., Gritsenko M.A., Camp D.G. II, Monroe M.E.,Moore R.J., Smith R.D.; J. Proteome Res. 4:2070-2080(2005). Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-85, AND MASS SPECTROMETRY. | |
"A proteomic analysis of human bile."; Kristiansen T.Z., Bunkenborg J., Gronborg M., Molina H.,Thuluvath P.J., Argani P., Goggins M.G., Maitra A., Pandey A.; Mol. Cell. Proteomics 3:715-728(2004). Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-85, AND MASS SPECTROMETRY. | |
"Isolation and primary structure of NGAL, a novel protein associatedwith human neutrophil gelatinase."; Kjeldsen L., Johnsen A.H., Sengelov H., Borregaard N.; J. Biol. Chem. 268:10425-10432(1993). Cited for: PROTEIN SEQUENCE OF 21-198. | |
Pyrrolidone carboxylic acid | |
Reference | PubMed |
"Isolation and primary structure of NGAL, a novel protein associatedwith human neutrophil gelatinase."; Kjeldsen L., Johnsen A.H., Sengelov H., Borregaard N.; J. Biol. Chem. 268:10425-10432(1993). Cited for: PROTEIN SEQUENCE OF 21-198. |